A pilot, open-label investigation of the efficacy of glucosamine for the treatment of major depression.

CONCLUSIONS: Encouraging preclinical results notwithstanding, glucosamine monotherapy does not appear to be effective against major depression. A more authoritative conclusion would require a randomized controlled trial. PMID: 32388446 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32388446?dopt=Abstract

Source: Asian Journal of Psychiatry - May 12, 2020 Category: Psychiatry Tags: Asian J Psychiatr Source Type: research